Kenneth L. Feenstra

757 total citations
12 papers, 610 citations indexed

About

Kenneth L. Feenstra is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, Kenneth L. Feenstra has authored 12 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pharmacology and 4 papers in Pharmacology. Recurrent topics in Kenneth L. Feenstra's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Kenneth L. Feenstra is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Kenneth L. Feenstra collaborates with scholars based in United States. Kenneth L. Feenstra's co-authors include James P. Sams, J G Slatter, Geoffrey W. Peng, Paul A. Bombardt, Langdon L. Miller, K. S. Cathcart, M J Hauer, Linda D. Compton, David Baker and Laura Pearson and has published in prestigious journals such as Drug Metabolism and Disposition, The Veterinary Journal and Current Drug Metabolism.

In The Last Decade

Kenneth L. Feenstra

12 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth L. Feenstra United States	7	229	204	201	198	111	12	610
James P. Sams United States	12	368 1.6×	247 1.2×	204 1.0×	212 1.1×	78 0.7×	17	817
I Bekersky United States	17	185 0.8×	149 0.7×	156 0.8×	123 0.6×	105 0.9×	37	814
Konrad E. Tomaszewski United States	11	225 1.0×	92 0.5×	342 1.7×	108 0.5×	90 0.8×	18	753
Thomas Mercier Switzerland	17	136 0.6×	73 0.4×	130 0.6×	184 0.9×	90 0.8×	33	685
Tomoko Yoshinari Japan	19	624 2.7×	207 1.0×	130 0.6×	175 0.9×	50 0.5×	33	1.2k
Tomoki Imaoka Japan	14	133 0.6×	385 1.9×	139 0.7×	49 0.2×	133 1.2×	20	718
Ricardo Nalda‐Molina Spain	11	102 0.4×	126 0.6×	62 0.3×	105 0.5×	30 0.3×	25	437
Yubo Xiao China	13	302 1.3×	54 0.3×	108 0.5×	187 0.9×	95 0.9×	21	587
Melva Louisa Indonesia	18	270 1.2×	165 0.8×	43 0.2×	64 0.3×	125 1.1×	128	953
J H Lin United States	13	146 0.6×	325 1.6×	209 1.0×	107 0.5×	192 1.7×	17	769

Countries citing papers authored by Kenneth L. Feenstra

Since Specialization

Citations

This map shows the geographic impact of Kenneth L. Feenstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth L. Feenstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth L. Feenstra more than expected).

Fields of papers citing papers by Kenneth L. Feenstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth L. Feenstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth L. Feenstra. The network helps show where Kenneth L. Feenstra may publish in the future.

Co-authorship network of co-authors of Kenneth L. Feenstra

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth L. Feenstra. A scholar is included among the top collaborators of Kenneth L. Feenstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth L. Feenstra. Kenneth L. Feenstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hu, Steven, et al.. (2020). Stability of Ketoprofen Methylester in Plasma of Different Species. Current Drug Metabolism. 22(3). 215–223. 4 indexed citations

Hu, Steven, C. Mazur, & Kenneth L. Feenstra. (2019). Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination ofIn VitroAssays and Pharmacokinetic Data from the Literature. Drug Metabolism Letters. 13(2). 123–131. 5 indexed citations

Hu, Steven, et al.. (2018). Pharmacokinetics and brain distribution of amitraz and its metabolites in rats. Environmental Toxicology and Pharmacology. 65. 40–45. 6 indexed citations

Hu, Steven, et al.. (2016). Assessment of inhibition of porcine hepatic cytochrome P450 enzymes by 48 commercial drugs. The Veterinary Journal. 211. 26–31. 9 indexed citations

Zaya, Matthew J., et al.. (2009). Current Cytochrome P450 Phenotyping Methods Applied to Metabolic Drug-Drug Interaction Prediction in Dogs. Drug Metabolism and Disposition. 38(3). 396–404. 14 indexed citations

Locuson, Charles W., Brian Ethell, Michael W. Voice, David Lee, & Kenneth L. Feenstra. (2008). Evaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase. Drug Metabolism and Disposition. 37(3). 457–461. 33 indexed citations

Slatter, J G, Luke A. Adams, Eliot Bush, et al.. (2002). Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica. 32(10). 907–924. 80 indexed citations

Slatter, J G, Dennis J. Stalker, Kenneth L. Feenstra, et al.. (2001). Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.. PubMed. 29(8). 1136–45. 203 indexed citations

Slatter, J. Greg, Larry J. Schaaf, James P. Sams, et al.. (2000). Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients. Drug Metabolism and Disposition. 28(4). 423–433. 241 indexed citations

10.

Slatter, J G, et al.. (1997). Metabolism of a bisphosphonate ester (PNU-91638) in rat. Xenobiotica. 27(10). 1039–1051. 2 indexed citations

11.

Slatter, J G, Kenneth L. Feenstra, M J Hauer, et al.. (1996). Metabolism of the bisphosphonate ester U-91502 in rats.. Drug Metabolism and Disposition. 24(1). 65–73. 7 indexed citations

12.

Feenstra, Kenneth L., et al.. (1996). Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture.. Drug Metabolism and Disposition. 24(2). 221–231. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact